$RVT

Royce Small-Cap Trust (NYSE: RVT) as of Jun 30, 2025 - Royce Value Trust (NYSE:RVT)

Oldest and largest small-cap closed-end fund Average weekly trading volume of approximately 1,219,732 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience

Original reporting
Benzinga · PRNewswire
Published Jul 30, 2025, 6:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 30, 2025, 7:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$RVT
Neutral
medium confidence
Mentioned
$RVT
AlphAI data visualization · based on Benzinga
Decision brief

The 30-second read

$RVTNeutralLow
01

Why it matters

The article confirms the fund's status but does not introduce new developments or risks that could influence its valuation.

02

Market read

The news has limited immediate trading relevance but provides useful background for long-term investors assessing the fund's stability.

03

What to watch

Potential upcoming changes in fund management or market conditions could alter the outlook; these are not discussed in the article.

Timing: low

Background

Royce Small-Cap Trust (RVT) is a well-established fund specializing in small-cap equities, with a long history and significant trading volume, indicating liquidity and investor interest.

Company-level read

Ticker impact

$RVTNeutralMedium confidence
Context

The news pertains directly to Royce Small-Cap Trust (RVT), providing updated information on its size, trading volume, and management experience, which are relevant for assessing investment and trading strategies.

Expected impact

Minimal short-term price movement expected; long-term impact depends on broader market conditions and fund performance.

Evidence & confidence

The news provides factual updates without indicating significant changes or catalysts that could affect the stock price substantially.

Market effects

Limited sector impact; the fund's performance may reflect broader small-cap market trends.

Minimal regional effects; the news is specific to a US-based fund.

Negligible; the fund's activity does not significantly influence global markets.

Counterpoint

While the news appears neutral, some investors might interpret the size and liquidity as a sign of stability, potentially supporting a buy-and-hold strategy.

Key entities

  • Royce Small-Cap Trust

    A large, established small-cap closed-end fund with extensive management experience.

Related articles

$GISMed

General Mills Announces Dana McNabb As CEO

General Mills' board elected Dana McNabb, current COO, as CEO effective January 2027, succeeding Jeff Harmening, who will become executive chair. McNabb, with 27 years at the company, has led key operating segments and functions. She aims to drive profitable growth through digital demand and supply chain modernization, building on Harmening's foundation.

$GISMed

General Mills Names First Woman CEO

General Mills has named Dana McNabb as its next CEO, the first woman to lead the company. McNabb, currently COO, will take over on January 1. Current CEO Jeff Harmening will become executive chairman. The board unanimously approved the change.

$HPEMedAI 8/10

HPE Networking chief links $1.2B Vultr neocloud win to ‘revenue synergy’ opportunity

Hewlett Packard Enterprise (HPE) secured a $1.2B deal with Vultr for its AMD Helios AI Rack system, highlighting revenue synergy opportunities. The deal involves deploying HPE's AI Rack in Vultr's U.S. data centers to support AI workloads. HPE's executive Rami Rahim stated this opens a new networking market, with Helios representing a billion-dollar opportunity over two years, and networking tray orders already exceeding $200M.

$LLYMedAI 8/10

Retatrutide Yields Significant Weight Loss in T2D

Eli Lilly's phase 3 TRIUMPH-2 study shows retatrutide, a triple hormonal agonist, achieved significant weight loss (up to 20.8%) and glycemic improvements in adults with type 2 diabetes (T2D) and obesity. The study, presented at EASD 2026, involved 1152 participants and showed retatrutide's efficacy estimand exceeded 20% weight reduction, a threshold not previously reached in T2D patients.

$BAMMedAI 9/10

U.S. – Korea Framework Advances Deployment of Westinghouse Nuclear Technology in the United States

The U.S. and Korea agreed on a framework committing up to $120B in Korean investment for constructing eight nuclear reactors in the U.S., including six Westinghouse AP1000 reactors and two Korean APR1400 reactors. The deal includes a 5-10% equity investment in Westinghouse by Korea. Brookfield Asset Management and Cameco are partners in the project, which aims to expand U.S. nuclear capacity to meet growing energy demand.